Filing Details

Accession Number:
0001415889-24-008316
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-03-18 17:40:14
Reporting Period:
2019-09-10
Accepted Time:
2024-03-18 17:40:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1759425 Mirum Pharmaceuticals Inc. MIRM Pharmaceutical Preparations (2834) 831281555
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1780347 Lara Longpre C/O Mirum Pharmaceuticals, Inc.
950 Tower Lane, Suite 1050
Foster City CA 94404
Chief Development Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-09-10 965 $10.64 105,372 No 4 P Direct
Common Stock Disposition 2023-01-09 1,003 $20.62 104,369 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 S Direct
Footnotes
  1. The weighted average purchase price for the transaction reported was $10.64, and the range of prices were between $10.20 and $10.8799. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
  2. Shares sold to cover tax witholding obligations associated with the vesting of restricted stock units.